로딩 중…
지수 로딩 중…
DongKook Life Science
303810· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,735-4.70%
2026-06-19
Price Chart
DongKook Life Science-40.54%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 87.48B KRW |
| Revenue | 128.38B KRW |
| Net Income | 1.20B KRW |
| Total Assets | 223.83B KRW |
| Net Assets | 133.64B KRW |
| Employees | 211 |
| Value | |
| P/E | 72.78x |
| P/B | 0.65x |
| PEG | 29.17x |
| P/S | 0.68x |
| EV/EBITDA | 43.69x |
| FCF Yield | -6.01% |
| Profitability | |
| ROE | 0.90% |
| ROA | 0.54% |
| Op. Margin | 2.17% |
| Revenue Growth | -5.61% |
| Earnings Growth | 2.50% |
| Financial Health | |
| Debt Ratio | 167.49% |
| Total Debt | 39.27B KRW |
| FCF | -5.26B KRW |
| Cash | 4.88B KRW |
| Current Ratio | 1.71x |
| Net Debt/EBITDA | 12.33x |
| Performance | |
| 1Y Return | -40.54% |
| 1M Return | -8.22% |
| From 52W High | -48.88% |
| 1Y MDD | -48.16% |
| Trading | |
| Volume | 63,181 shares |
| Foreign Own. | 2.45% |
| Per Share | |
| EPS | 272 KRW |
| BPS | 4,178 KRW |
Company Info
Dongguk Pharmaceutical Life Science, established in 2017 and listed on KOSDAQ in 2025, manufactures and sells contrast agents, and distributes medical devices and diagnostic equipment. As a specialized contrast agent company, it launched Korea's first First generic contrast agent, Pamiray, and has 17 partners in 25 countries. Leveraging its radiology expertise and sales network from its contrast agent business, the company is expanding its AI medical device business and providing Total Patient Care. It is headquartered in Gangnam-gu, Seoul.